RecruitingNot ApplicableNCT05459935

Photobiomodulation for Pediatric Hypertrophic Tonsils

Treatment of Pediatric Hypertrophic Tonsils and Pediatric Obstructive Sleep Apnea by Non-invasive Photobiomodulation


Sponsor

University of Alberta

Enrollment

64 participants

Start Date

Oct 15, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Pediatric obstructive sleep apnea is a medical condition where a child has great difficulty with breathing, or stops breathing all together, while asleep. This is a medical condition for which the primary treatment is usually a surgery targeted towards removing swollen tonsils and adenoids. However, surgical removal of tonsils and adenoids comes with its own risks of complications during and after surgery including secondary hemorrhage and long term increased risks for respiratory and infectious diseases. Perhaps more importantly, surgical removal of swollen tonsils and adenoids does not guarantee successful treatment of a child's obstructive sleep apnea. The use of laser light therapy in a non-cutting manner (known as photobiomodulation and abbreviated as PBM) has been a relatively new development within medicine. Recently, dentists have begun to use PBM as a method to treat adult snoring and, with lesser success, adult obstructive sleep apnea. To date, there are no known side effects to the use of PBM for the treatment of any sleep breathing disorders. However, no research has been published on the use of PBM for the treatment of pediatric obstructive sleep apnea or swollen tonsils in children The purpose of this project is to determine whether photobiomodulation can provide a beneficial effect on pediatric hypertrophic tonsils and pediatric obstructive sleep apnea and, if it does, to create the appropriate workflow, referral pathways, and treatment parameters for clinicians to provide this treatment as a multidisciplinary approach in a clinical setting. The investigators hypothesize that photobiomodulation can be used successfully to decrease the pediatric hypertrophic tonsils in children with symptoms of an pediatric obstructive sleep apnea and will also result in improved AHI scores (be able to breath significantly better when sleeping) in these children.


Eligibility

Min Age: 6 YearsMax Age: 12 Years

Inclusion Criteria3

  • Brodsky visually graded tonsils 3/4
  • patient must assent, parent must consent, to all pre and post follow up including sleep testing
  • patient and parent must agree to normal referral protocols regardless of participation within this study or not

Exclusion Criteria3

  • visual indication of cancerous growth
  • currently under treatment (pharmacologic, other) for hypertrophic tonsils
  • already scheduled for surgical intervention of hypertrophic tonsils

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPBM Tonsil Arm

exposure of hypertrophic tonsils to photobiomodulation

DEVICESham PBM Tonsil Arm

non-powered exposure of hypertrophic tonsils to photobiomodulation


Locations(1)

Enjoy Dental

Edmonton, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05459935


Related Trials